VC firm
Pivotal bioVenture Partners
Also known as Nan Fung Life Sciences, Pivotal Life Sciences
- Investor type
- VC
- Investing status
- Activeas of 2026-09-17Source (opens in a new tab)
- Headquarters
- San Francisco, CA, United States
- Founded
- 2017
- Assets under management
- $586MForm ADV private fund GAV, as of 2026-06-25Source (opens in a new tab)
- Funds
- 2
- Legal name
- PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC
Claim, correct or request removal
Record updated 29 September 2026
About
Established in 2017, we are a life sciences venture capital firm investing in transformative therapeutic-focused healthcare companies across North America and Europe.
Investment approach
- Thesis
- Our strategy is to invest in companies of all stages, with a primary focused on “high impact” therapeutics – solutions that address growing unmet medical needs and with near-curative or otherwise transformative disease management potential.Source (opens in a new tab)
- Investing status notes
- We provide financing and guidance at all stages in a company’s evolution, from company creation through clinical development and commercialization.
Funds
- PIVOTAL BIOVENTURE PARTNERS FUND I, L.P.
- Main fund
- PIVOTAL BIOVENTURE PARTNERS FUND II, L.P.
- Main fund
SEC registration
- Registered adviser
- PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC
- CRD number
- 287988 (opens in a new tab)
- SEC file number
- 802-110211
- Registration
- Exempt reporting adviser
- Regulatory AUM
- $586Mas of 2026-06-25
- Private funds reported
- 2
- Principal office
- SAN FRANCISCO, CA, United States
Locations
- Office
- Shanghai, China
- Office
- Hong Kong, Hong Kong
- Office
- Cambridge, MA, United States
- Office
- San Francisco, CA, United States
Loading relationship preview